Strategies for the prevention of perinatal hepatitis B transmission in a marginalized population on the Thailand-Myanmar border: a cost-effectiveness analysis

<strong>Background</strong> Data on the cost effectiveness of hepatitis B virus (HBV) screening and vaccination strategies for prevention of vertical transmission of HBV in resource limited settings is sparse. <strong>Methods</strong> A decision tree model of HBV prevention...

Full description

Bibliographic Details
Main Authors: Devine, A, Harvey, R, Min, A, Gilder, M, Paw, M, Kang, J, Watts, I, Hanboonkunupakarn, B, Nosten, F, McGready, R
Format: Journal article
Published: BioMed Central 2017
_version_ 1797058652028272640
author Devine, A
Harvey, R
Min, A
Gilder, M
Paw, M
Kang, J
Watts, I
Hanboonkunupakarn, B
Nosten, F
McGready, R
author_facet Devine, A
Harvey, R
Min, A
Gilder, M
Paw, M
Kang, J
Watts, I
Hanboonkunupakarn, B
Nosten, F
McGready, R
author_sort Devine, A
collection OXFORD
description <strong>Background</strong> Data on the cost effectiveness of hepatitis B virus (HBV) screening and vaccination strategies for prevention of vertical transmission of HBV in resource limited settings is sparse. <strong>Methods</strong> A decision tree model of HBV prevention strategies utilised data from a cohort of 7071 pregnant women on the Thailand-Myanmar border using a provider perspective. All options included universal HBV vaccination for newborns in three strategies: (1) universal vaccination alone; (2) universal vaccination with screening of women during antenatal visits with rapid diagnostic test (RDT) plus HBV immune globulin (HBIG) administration to newborns of HBV surface antigen positive women; and (3) universal vaccination with screening of women during antenatal visits plus HBIG administration to newborns of women testing HBV e antigen positive by confirmatory test. At the time of the study, the HBIG after confirmatory test strategy was used. The costs in United States Dollars (US$), infections averted and incremental cost effectiveness ratios (ICERs) were calculated and sensitivity analyses were conducted. A willingness to pay threshold of US$1200 was used. <strong>Results</strong> The universal HBV vaccination was the least costly option at US$4.33 per woman attending the clinic. The HBIG after (RDT) strategy had an ICER of US$716.78 per infection averted. The HBIG after confirmatory test strategy was not cost-effective due to extended dominance. The one-way sensitivity analysis showed that while the transmission parameters and cost of HBIG had the biggest impact on outcomes, the HBIG after confirmatory test only became a cost-effective option when a low test cost was used or a high HBIG cost was used. The probabilistic sensitivity analysis showed that HBIG after RDT had an 87% likelihood of being cost-effective as compared to vaccination only at a willingness to pay threshold of US$1200. <strong>Conclusions</strong> HBIG following confirmatory test is not a cost-effective strategy for preventing vertical transmission of HBV in the Thailand-Myanmar border population. By switching to HBIG following rapid diagnostic test, perinatal infections will be reduced by nearly one third. This strategy may be applicable to similar settings for marginalized populations where the confirmatory test is not logistically possible.
first_indexed 2024-03-06T19:53:21Z
format Journal article
id oxford-uuid:24b84c98-177e-4186-8563-1b9c7a559247
institution University of Oxford
last_indexed 2024-03-06T19:53:21Z
publishDate 2017
publisher BioMed Central
record_format dspace
spelling oxford-uuid:24b84c98-177e-4186-8563-1b9c7a5592472022-03-26T11:51:38ZStrategies for the prevention of perinatal hepatitis B transmission in a marginalized population on the Thailand-Myanmar border: a cost-effectiveness analysisJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:24b84c98-177e-4186-8563-1b9c7a559247Symplectic Elements at OxfordBioMed Central2017Devine, AHarvey, RMin, AGilder, MPaw, MKang, JWatts, IHanboonkunupakarn, BNosten, FMcGready, R<strong>Background</strong> Data on the cost effectiveness of hepatitis B virus (HBV) screening and vaccination strategies for prevention of vertical transmission of HBV in resource limited settings is sparse. <strong>Methods</strong> A decision tree model of HBV prevention strategies utilised data from a cohort of 7071 pregnant women on the Thailand-Myanmar border using a provider perspective. All options included universal HBV vaccination for newborns in three strategies: (1) universal vaccination alone; (2) universal vaccination with screening of women during antenatal visits with rapid diagnostic test (RDT) plus HBV immune globulin (HBIG) administration to newborns of HBV surface antigen positive women; and (3) universal vaccination with screening of women during antenatal visits plus HBIG administration to newborns of women testing HBV e antigen positive by confirmatory test. At the time of the study, the HBIG after confirmatory test strategy was used. The costs in United States Dollars (US$), infections averted and incremental cost effectiveness ratios (ICERs) were calculated and sensitivity analyses were conducted. A willingness to pay threshold of US$1200 was used. <strong>Results</strong> The universal HBV vaccination was the least costly option at US$4.33 per woman attending the clinic. The HBIG after (RDT) strategy had an ICER of US$716.78 per infection averted. The HBIG after confirmatory test strategy was not cost-effective due to extended dominance. The one-way sensitivity analysis showed that while the transmission parameters and cost of HBIG had the biggest impact on outcomes, the HBIG after confirmatory test only became a cost-effective option when a low test cost was used or a high HBIG cost was used. The probabilistic sensitivity analysis showed that HBIG after RDT had an 87% likelihood of being cost-effective as compared to vaccination only at a willingness to pay threshold of US$1200. <strong>Conclusions</strong> HBIG following confirmatory test is not a cost-effective strategy for preventing vertical transmission of HBV in the Thailand-Myanmar border population. By switching to HBIG following rapid diagnostic test, perinatal infections will be reduced by nearly one third. This strategy may be applicable to similar settings for marginalized populations where the confirmatory test is not logistically possible.
spellingShingle Devine, A
Harvey, R
Min, A
Gilder, M
Paw, M
Kang, J
Watts, I
Hanboonkunupakarn, B
Nosten, F
McGready, R
Strategies for the prevention of perinatal hepatitis B transmission in a marginalized population on the Thailand-Myanmar border: a cost-effectiveness analysis
title Strategies for the prevention of perinatal hepatitis B transmission in a marginalized population on the Thailand-Myanmar border: a cost-effectiveness analysis
title_full Strategies for the prevention of perinatal hepatitis B transmission in a marginalized population on the Thailand-Myanmar border: a cost-effectiveness analysis
title_fullStr Strategies for the prevention of perinatal hepatitis B transmission in a marginalized population on the Thailand-Myanmar border: a cost-effectiveness analysis
title_full_unstemmed Strategies for the prevention of perinatal hepatitis B transmission in a marginalized population on the Thailand-Myanmar border: a cost-effectiveness analysis
title_short Strategies for the prevention of perinatal hepatitis B transmission in a marginalized population on the Thailand-Myanmar border: a cost-effectiveness analysis
title_sort strategies for the prevention of perinatal hepatitis b transmission in a marginalized population on the thailand myanmar border a cost effectiveness analysis
work_keys_str_mv AT devinea strategiesforthepreventionofperinatalhepatitisbtransmissioninamarginalizedpopulationonthethailandmyanmarborderacosteffectivenessanalysis
AT harveyr strategiesforthepreventionofperinatalhepatitisbtransmissioninamarginalizedpopulationonthethailandmyanmarborderacosteffectivenessanalysis
AT mina strategiesforthepreventionofperinatalhepatitisbtransmissioninamarginalizedpopulationonthethailandmyanmarborderacosteffectivenessanalysis
AT gilderm strategiesforthepreventionofperinatalhepatitisbtransmissioninamarginalizedpopulationonthethailandmyanmarborderacosteffectivenessanalysis
AT pawm strategiesforthepreventionofperinatalhepatitisbtransmissioninamarginalizedpopulationonthethailandmyanmarborderacosteffectivenessanalysis
AT kangj strategiesforthepreventionofperinatalhepatitisbtransmissioninamarginalizedpopulationonthethailandmyanmarborderacosteffectivenessanalysis
AT wattsi strategiesforthepreventionofperinatalhepatitisbtransmissioninamarginalizedpopulationonthethailandmyanmarborderacosteffectivenessanalysis
AT hanboonkunupakarnb strategiesforthepreventionofperinatalhepatitisbtransmissioninamarginalizedpopulationonthethailandmyanmarborderacosteffectivenessanalysis
AT nostenf strategiesforthepreventionofperinatalhepatitisbtransmissioninamarginalizedpopulationonthethailandmyanmarborderacosteffectivenessanalysis
AT mcgreadyr strategiesforthepreventionofperinatalhepatitisbtransmissioninamarginalizedpopulationonthethailandmyanmarborderacosteffectivenessanalysis